Jun 4Inflection Biosciences Announces the Appointment of Professor Martin Dreyling to its Advisory PanelDublin, Ireland, June 4, 2020 Inflection Biosciences Ltd, a company developing innovative small molecule therapeutics for the treatment ...
May 12Inflection Biosciences Announces Participation at Upcoming Industry Conferences Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, to...
Feb 19Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific OfficerDublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cance...
Feb 6Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the trea...
Jan 31Inflection Biosciences to Present at BIO CEO & Investor Conference 2020Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Nov 26, 2019Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer...
Oct 30, 2019Inflection Biosciences Announces Passing of Co-Founder and Board Member John ScanlanDublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board ...
Sep 9, 2019Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference onDublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of canc...
Aug 7, 2019Inflection Biosciences Announces Publication of Positive Data for PIM/PI3K/mTOR InhibitorDublin, Ireland, August 7, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, t...
Jul 18, 2019Inflection Biosciences and AUM Biosciences announce Global License Agreement for PIM/PI3K/mTOR Dublin, Ireland, 18 July 2019 – Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of ca...
